David P Perry's Net Worth
$2.11 Million
Who is David P Perry?
David P Perry has an estimated net worth of $2.11 Million. This is based on reported shares across multiple companies, which include Anacor Pharmaceuticals Inc, Evelo Biosciences, Inc., Better Therapeutics, Inc., and NEXPRISE INC.
SEC CIK
David P Perry's CIK is 0001105941
Past Insider Trading and Trends
2021 was David P Perry's most active year for acquiring shares with 10 total transactions. David P Perry's most active month to acquire stocks was the month of April. 2014 was David P Perry's most active year for disposing of shares, totalling 8 transactions. David P Perry's most active month to dispose stocks was the month of November. 2024 saw David P Perry paying a total of $409,999.86 for 2,311,348 shares, this is the most they've acquired in one year. In 2014 David P Perry cashed out on 145,000 shares for a total of $2,630,510.25, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Anacor Pharmaceuticals Inc No price found
President and CEODavid P Perry owns 361,306 units of Common Stock.acquired a total of 285,480 shares in Anacor Pharmaceuticals Inc at a cost of $171,288.00, David also disposed a total of 185,328 shares of Anacor Pharmaceuticals Inc equalling to $3,285,097.51.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -15.25% | -65.00K |
$20.22 | -$1,314,396.50 | 361.31K |
Scheduled
|
Mar 4 - Mar 5
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 7
| |||
Form 4
| -3.40% | -15.00K |
$17.00 | -$255,006.75 | 426.31K |
Scheduled
|
Feb 4 - Feb 5
| ||
Form 4
| -12.84% | -65.00K |
$16.32 | -$1,061,107.00 | 441.31K |
Scheduled
|
Jan 8 - Jan 9
| ||
Form 4
| +93.87% | 245.15K |
$8.42 | -$483,299.26 | 506.31K |
Scheduled
|
Dec 5 - Dec 9
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 31
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Evelo Biosciences, Inc. (EVLO) Snapshot price: $0.0001
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8 - Jun 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Better Therapeutics, Inc. (BTTX) Snapshot price: $0.008
Executive ChairmanDavid P Perry owns 2,416,634 units of Common Stock which is worth $19,333.07. From 2021 to 2024 David P Perry acquired a total of 2,416,634 shares in Better Therapeutics, Inc. at a cost of $1,025,029.89.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +53.27% | 839.89K |
$0.19 | $160,000.00 | 2.42M |
Feb 9
| |||
Form 4
| +1,397.58% | 1.47M |
$0.17 | $249,999.86 | 1.58M |
Jan 9
| |||
Form 4
| +3.69% | 3.75K |
—
|
—
| 105.29K |
Dec 18
| |||
Form 4
| +10.45% | 1.23M |
$0.73 | $899,999.55 | 13.03M |
Jul 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 7
| |||
Form 4
| +47.49% | 4.97M |
$0.83 | $4,100,000.02 | 15.43M |
Apr 10
| |||
Form 4
| +97.02% | 50K |
$2.05 | $102,597.54 | 101.54K |
Sep 15 - Sep 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 4
| +34.59% | 10.83M |
$9.97 | $3,512,432.48 | 42.14M |
Apr 30 - Oct 28
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
NEXPRISE INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 22
| |||
No matching records found |